<img width="364" height="150" src="https://korecyte.com/wp-content/uploads/2023/07/korecyte-bio-brand-logo-for-header.png" class="attachment-large size-large" alt="Korecyte Bio is an international biotech startup based between the Netherlands and United Kingdom that was established in 2023. Our mission is to develop next-generation CAR-T cellular immunotherapies" loading="lazy" decoding="async" srcset="https://korecyte.com/wp-content/uploads/2023/07/korecyte-bio-brand-logo-for-header.png 364w, https://korecyte.com/wp-content/uploads/2023/07/korecyte-bio-brand-logo-for-header-300x124.png 300w" sizes="(max-width: 364px) 100vw, 364px" />

<img width="364" height="150" src="https://korecyte.com/wp-content/uploads/2023/07/korecyte-bio-brand-logo-for-header.png" class="attachment-large size-large" alt="Korecyte Bio is an international biotech startup based between the Netherlands and United Kingdom that was established in 2023. Our mission is to develop next-generation CAR-T cellular immunotherapies" loading="lazy" decoding="async" srcset="https://korecyte.com/wp-content/uploads/2023/07/korecyte-bio-brand-logo-for-header.png 364w, https://korecyte.com/wp-content/uploads/2023/07/korecyte-bio-brand-logo-for-header-300x124.png 300w" sizes="(max-width: 364px) 100vw, 364px" />

Dutch Life Science Conference

Korecyte Bio presented its ambitions within the CAR-T field at the Dutch Life Science Conference 2023 in Leiden. The day was packed with meaningful discussions, engaging with industry leaders, exploring innovative solutions and potential collaborations in the biopharma industry. There’s still much to be gained for better patient curing, which forms the core of our activities.